Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
Anna Heintz‐Buschart, Urvashi Pandey, Tamara Wicke, et al.
Movement Disorders (2017) Vol. 33, Iss. 1, pp. 88-98
Open Access | Times Cited: 500

Showing 1-25 of 500 citing articles:

The Microbiota-Gut-Brain Axis
John F. Cryan, Kenneth J. O’Riordan, Caitlin S.M. Cowan, et al.
Physiological Reviews (2019) Vol. 99, Iss. 4, pp. 1877-2013
Open Access | Times Cited: 3485
Human gut microbiome: hopes, threats and promises
Patrice D. Cani
Gut (2018) Vol. 67, Iss. 9, pp. 1716-1725
Open Access | Times Cited: 1153
The gut microbiome in neurological disorders
John F. Cryan, Kenneth J. O’Riordan, Kiran Sandhu, et al.
The Lancet Neurology (2019) Vol. 19, Iss. 2, pp. 179-194
Closed Access | Times Cited: 1002
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Vayu Maini Rekdal, Elizabeth N. Bess, Jordan E. Bisanz, et al.
Science (2019) Vol. 364, Iss. 6445
Open Access | Times Cited: 590
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
Stefano Romano, George M. Savva, Janis R. Bedarf, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 497
Role and Mechanism of Gut Microbiota in Human Disease
Yinwei Chen, Jinghua Zhou, Li Wang
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 451
Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 13: suitability of taxonomic units notified to EFSA until September 2020
Kostas Koutsoumanis, Ana Allende, Avelino Álvarez‐Ordóñez, et al.
EFSA Journal (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 410
The microbiome of the upper respiratory tract in health and disease
Christina Kumpitsch, Kaisa Koskinen, Veronika Schöpf, et al.
BMC Biology (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 402
Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice
Jing Sun, Jing‐Xuan Xu, Yi Ling, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 395
Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
Zhe Zhao, Jingwen Ning, Xiu‐Qi Bao, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 377
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
Chin‐Hsien Lin, Chieh‐Chang Chen, Han‐Lin Chiang, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 370
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
Yiwei Qian, Xiaodong Yang, Shaoqing Xu, et al.
Brain Behavior and Immunity (2018) Vol. 70, pp. 194-202
Open Access | Times Cited: 346
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
Michela Barichella, Marco Severgnini, Roberto Cilia, et al.
Movement Disorders (2018) Vol. 34, Iss. 3, pp. 396-405
Closed Access | Times Cited: 329
Next generation probiotics in disease amelioration
Chih‐Jung Chang, Tzu-Lung Lin, Yu‐Ling Tsai, et al.
Journal of Food and Drug Analysis (2019) Vol. 27, Iss. 3, pp. 615-622
Open Access | Times Cited: 301
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Velma T. E. Aho, Pedro A. B. Pereira, Sari Voutilainen, et al.
EBioMedicine (2019) Vol. 44, pp. 691-707
Open Access | Times Cited: 301
Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease
Hiroshi Nishiwaki, Mikako Ito, Tomohiro Ishida, et al.
Movement Disorders (2020) Vol. 35, Iss. 9, pp. 1626-1635
Open Access | Times Cited: 278
Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 276
Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
Michaela Johnson, Benjamin Stecher, Viviane Labrie, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 1, pp. 4-13
Open Access | Times Cited: 273
Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
Sara Gerhardt, M. Hasan Mohajeri
Nutrients (2018) Vol. 10, Iss. 6, pp. 708-708
Open Access | Times Cited: 264
Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease
Mihai Cirstea, Adam C. Yu, Ella Golz, et al.
Movement Disorders (2020) Vol. 35, Iss. 7, pp. 1208-1217
Closed Access | Times Cited: 251
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Ai Huey Tan, Shen‐Yang Lim, Anthony E. Lang
Nature Reviews Neurology (2022) Vol. 18, Iss. 8, pp. 476-495
Closed Access | Times Cited: 214
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Ashley S. Harms, Sara A. Ferreira, Marina Romero‐Ramos
Acta Neuropathologica (2021) Vol. 141, Iss. 4, pp. 527-545
Open Access | Times Cited: 213
The Role of Lipids in Parkinson’s Disease
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Cells (2019) Vol. 8, Iss. 1, pp. 27-27
Open Access | Times Cited: 204
Making Sense of … the Microbiome in Psychiatry
Thomaz F. S. Bastiaanssen, Caitlin S.M. Cowan, Marcus J. Claesson, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 1, pp. 37-52
Open Access | Times Cited: 198
The Microbiome as a Modifier of Neurodegenerative Disease Risk
Ping Fang, Sabeen A. Kazmi, Kelly G. Jameson, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 201-222
Open Access | Times Cited: 191
Page 1 - Next Page

Scroll to top